Published online Jun 20, 2024. doi: 10.5662/wjm.v14.i2.91889
Revised: February 10, 2024
Accepted: March 28, 2024
Published online: June 20, 2024
Processing time: 157 Days and 20.4 Hours
However, the connection between smoking and the prognosis of patients with bladder cancer remains unclear.
To determine whether smoking is linked to the recurrence and progression of bladder cancer.
As of July 20, 2022, relevant English-language research was identified by sear
A total of 12 studies were included in this meta-analysis. The combined analysis revealed that tobacco exposure was associated with a significantly greater recurrence rate than nonsmoking status [odd ratios (OR) = 1.76, 95%CI: 1.84-2.93], and the progression of bladder cancer was significantly greater in smokers than in nonsmokers (OR = 1.21, 95%CI: 1.02-1.44). Stratified analysis further revealed that current smokers were more likely to experience relapse than never-smokers were (OR = 1.85, 95%CI: 1.11-3.07). Former smokers also had a greater risk of relapse than did never-smokers (OR = 1.73, 95%CI: 1.09-2.73). Subgroup analysis indi
This meta-analysis revealed that tobacco exposure may be a significant risk factor for both the recurrence and progression of bladder cancer.
Core Tip: In this meta-analysis, 12 studies were included to investigate the connection between smoking and the prognosis of bladder cancer patients. The results showed that tobacco exposure was associated with a significantly greater recurrence rate and faster progression of bladder cancer than nonsmoking status. Subgroup analysis further revealed that current and former smokers had a greater risk of relapse than did never smokers, and non-Caucasians may be more susceptible to bladder cancer recurrence than Caucasians are. Therefore, smoking is a major risk factor for bladder cancer recurrence and progression, and cessation of smoking is recommended. Regular follow-up and treatment are crucial for reducing the risk of smoking.
